-
DiscoveryFactory foreman keeps liver’s line workers on task
A complex protein module keeps the liver’s biochemical factory running smoothly and at capacity.
Discovery -
DiscoveryHow scientists aim to expand immunotherapy options for cancer patients
Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients
Discovery -
DiscoveryIntractable tumor cells crippled
Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.
Discovery -
DiscoveryLeveraging the liver’s ability to heal scarred tissue
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
Discovery -
DiscoveryNeuroscientists restore cell-to-cell signaling and sociability in autism models
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
Discovery -
DiscoveryNovartis and Pfizer join forces to upend oncology dogma
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
Discovery -
DiscoveryRare speed on a rare disease
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
Discovery -
DiscoveryStepping toward regenerative medicine for diabetes
Discovery points toward treatment options beyond insulin injections
Discovery -
DiscoveryCompounds spur insulin-producing cells to replicate in the lab
Discovery -
DiscoveryClinical trials make a move toward mice
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
Discovery -
DiscoveryGetting down to the roots of Alzheimer’s disease
Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.
Discovery -
DiscoveryStopping Alzheimer's disease before it starts
Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.
Discovery